A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: Comment

Evidence-Based Ophthalmology

Volumn 11, Issue 1, 2010, Pages 22-23

  Benson, William B ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 75749153036     PISSN: 15559203     EISSN: 15559211     Source Type: Journal    
DOI: 10.1097/IEB.0b013e3181c70dc3     Document Type: Note

References (1)

1. Spaeth G, De Barros D, Fudemberg S. Visual loss caused by corticosteroid-induced glaucoma: how to avoid it. Retina. 2009;29:1057-1061.